Tofacitinib Rescue for Refractory Drug‐Induced Liver Injury With Severe DRESS : A Prospective Proof‐of‐Concept Study
Liver International · 2026
DOI: 10.1111/liv.70578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Jingyan Gu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Piperidines, Pyrimidines, Chemical and Drug Induced Liver Injury, Drug Hypersensitivity Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Drug‐induced liver injury (DILI) with severe DRESS carries high mortality, yet rescue therapies for corticosteroid‐refractory cases remain undefined. We hypothesized that JAK inhibition could reverse refractory liver injury by targeting the underlying cytokine storm. In this prospective proof‐of‐concept study, consecutive patients with severe DRESS‐associated DILI refractory to corticosteroids (persistent/worsening liver injury) received oral tofacitinib rescue. Key assessments were the normalisation of liver biochemistries. Despite initial corticosteroids, all four patients exhibited progressive severe injury (median peak ALT 1126 U/L). Tofacitinib rapidly reversed liver injury in all cases. Transaminases normalised or near‐normalised (median: 48 days), total bilirubin normalised, and cutaneous symptoms resolved completely. Notably, baseline positive autoantibodies seroconverted to negative. No severe adverse events occurred (median follow‐up: 274 days). Tofacitinib shows promise as a rescue strategy for corticosteroid‐refractory DILI with severe DRESS. The rapid recovery underscores the JAK–STAT pathway's pathogenic role in this setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Peking University Third Hospital, Beijing, China.
- Department of Pharmacy, Peking University Third Hospital, Beijing, China.
- Department of Pathology, Peking University Third Hospital, Beijing, China.
- Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
ORCID-Profile: Wenhui Wang
Zitieren
APA
Gu, J., Wang, Y., Wang, X., Yan, Y., Pei, F., He, T., Zhang, C., Li, J., & Wang, W. (2026). Tofacitinib Rescue for Refractory Drug‐Induced Liver Injury With Severe DRESS : A Prospective Proof‐of‐Concept Study. Liver International. https://doi.org/10.1111/liv.70578
Vancouver
Gu J, Wang Y, Wang X, Yan Y, Pei F, He T, et al. Tofacitinib Rescue for Refractory Drug‐Induced Liver Injury With Severe DRESS : A Prospective Proof‐of‐Concept Study. Liver International. 2026. doi:10.1111/liv.70578
BibTeX
@article{Gu2026,
author = {Gu, Jingyan and Wang, Yuan and Wang, Xiaoyu and Yan, Yingying and Pei, Fei and He, Tianyu and Zhang, Chunlei and Li, Jun and Wang, Wenhui},
title = {Tofacitinib Rescue for Refractory Drug‐Induced Liver Injury With Severe DRESS : A Prospective Proof‐of‐Concept Study},
journal = {Liver International},
year = {2026},
doi = {10.1111/liv.70578}
}
EUVIMED